Biopharmaceutical companies are developing 907 biologic vaccines and drugs for more than 100 conditions, according to a Pharmaceutical Research and Manufacturers of America report. The lineup includes 134 vaccines for infectious diseases, 338 drugs for cancer, 71 for autoimmune diseases and 58 for cardiovascular diseases.
Report: 907 biotech vaccines and therapies in the pipeline
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|